David James Pinato

David James Pinato is an Associate Professor in the Department of Translational Medicine at Universita' degli Studi del Piemonte Orientale 'Amedeo Avogadro'. His research focuses on oncology, immunotherapy, and molecular biomarkers in cancer treatment, particularly in hepatocellular carcinoma and urothelial carcinoma. He leads projects on anti-tumour immunity and clinical applications of circulating tumor DNA (ctDNA).

Education details are not explicitly provided, but his professional trajectory includes roles as Principal Investigator (PI) and Co-Investigator (CoI) in major grants. His research interests emphasize translational medicine, with a focus on precision oncology and immunotherapy response prediction.

Dr. Pinato's recent work highlights ctDNA dynamics in colorectal cancer, genomic alterations in urothelial carcinoma, and risk stratification in hepatocellular carcinoma. His projects include collaborations with institutions globally to develop diagnostic tools and therapeutic strategies. Awards are not listed, but his extensive publication record reflects significant contributions to clinical oncology.

He leads the 'Integrated characterisation of anti-tumour immunity following neoadjuvant immunotherapy of Hepatocellular Carcinoma' (AIRC-funded) and contributes to antibody development for diagnostic imaging (MUR-funded). His team explores AI-driven models for predicting immunotherapy efficacy in lung cancer.